These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33181758)

  • 1. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.
    Güner A; Kalçik M; Aykan AÇ; Gürsoy MO; Kalkan AK; Astarcioğlu MA; Ertürk M; Uzun F; Güner EG; Yildiz M; Özkan M
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):536-542. PubMed ID: 33181758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].
    Zhao HG; Wang SX; Lu ZN; Yan XX; Lyu ZC; Peng FH; Wu Y; Gao X; Hua L; Jing ZC; Xu XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):314-317. PubMed ID: 28545283
    [No Abstract]   [Full Text] [Related]  

  • 3. An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism.
    Kaymaz C; Akbal OY; Keskin B; Tokgoz HC; Hakgor A; Karagoz A; Tanyeri S; Kultursay B; Kulahcioglu S; Dogan C; Bayram Z; Efe SÇ; Erkılınç A; Tanboga IH; Akbulut M; Ozdemir N; Tapson V; Konstantinides S
    Curr Vasc Pharmacol; 2022; 20(4):370-378. PubMed ID: 36324223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism.
    Surgit O; Güner A; Türkmen İ; Kahraman S; Serbest NG; Güner EG; Uzun F; Ertürk M; Yildiz M
    Ulus Travma Acil Cerrahi Derg; 2023 Jun; 29(6):677-684. PubMed ID: 37278082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
    Piazza G; Hohlfelder B; Jaff MR; Ouriel K; Engelhardt TC; Sterling KM; Jones NJ; Gurley JC; Bhatheja R; Kennedy RJ; Goswami N; Natarajan K; Rundback J; Sadiq IR; Liu SK; Bhalla N; Raja ML; Weinstock BS; Cynamon J; Elmasri FF; Garcia MJ; Kumar M; Ayerdi J; Soukas P; Kuo W; Liu PY; Goldhaber SZ;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1382-1392. PubMed ID: 26315743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-directed thrombolytic intervention is effective for patients with massive and submassive pulmonary embolism.
    Akin H; Al-Jubouri M; Assi Z; Acino R; Sepanski D; Comerota AJ
    Ann Vasc Surg; 2014 Oct; 28(7):1589-94. PubMed ID: 24911801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit.
    Kalkan ME; Yildiz M; Ak HY; Zencirkiran Agus H; Ozsahin Y; Aykan AC; Oksen D
    Kardiologiia; 2020 Aug; 60(7):86-90. PubMed ID: 33155945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus.
    Yildiz M; Karakoyun S; Acar RD; Ozkan M
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.
    Bagla S; Smirniotopoulos JB; van Breda A; Sheridan MJ; Sterling KM
    J Vasc Interv Radiol; 2015 Jul; 26(7):1001-6. PubMed ID: 25704224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism.
    Piazza G; Sterling KM; Tapson VF; Ouriel K; Sharp ASP; Liu PY; Goldhaber SZ
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009012. PubMed ID: 32757658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
    Rothschild DP; Goldstein JA; Bowers TR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial.
    Özkan M; Gündüz S; Biteker M; Astarcioglu MA; Çevik C; Kaynak E; Yıldız M; Oğuz E; Aykan AÇ; Ertürk E; Karavelioğlu Y; Gökdeniz T; Kaya H; Gürsoy OM; Çakal B; Karakoyun S; Duran N; Özdemir N
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Effects of Ultrasound-Assisted, Catheter-Directed, Very Low-Dose, Short-Time Duration Thrombolysis in Acute Intermediate-High Risk Pulmonary Embolism (from the EKOS-PL Study).
    Stępniewski J; Kopeć G; Musiałek P; Magoń W; Jonas K; Waligóra M; Sobczyk D; Podolec P
    Am J Cardiol; 2021 Feb; 141():133-139. PubMed ID: 33220318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.
    Zhang LY; Gao BA; Jin Z; Xiang GM; Gong Z; Zhang TT; Lu HF; Wang YQ; Gong Y; Lu C; Huang WL
    Saudi Med J; 2018 Nov; 39(11):1090-1095. PubMed ID: 30397707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Duration Catheter-directed Thrombolysis for Acute Pulmonary Embolism Rapidly Improves Acute Cardiac Function.
    Al-Nouri O; Locham S; Mannava K; Malas MB
    Ann Vasc Surg; 2021 Apr; 72():373-382. PubMed ID: 33227469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis.
    Carroll BJ; Goldhaber SZ; Liu PY; Piazza G
    Vasc Med; 2017 Aug; 22(4):324-330. PubMed ID: 28625110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism.
    Patel DC; Gaba RC; Liu L; Lokken RP
    PLoS One; 2019; 14(2):e0211701. PubMed ID: 30726288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.